Altai Protocol Library New Protocol: Datopotamab deruxtecan with Durvalumab for Triple-Negative Breast Cancer U. Darda Bayraktar, MD 2026-06-17
Altai Protocol Library New Drug: Daraxonrasib for Previously Treated Pancreatic Cancer U. Darda Bayraktar, MD 2026-06-17
Altai Protocol Library New Reference: Carboplatin Addition to (Neo)Adjuvant Therapy in Triple-Negative Breast Cancer U. Darda Bayraktar, MD 2026-06-17
Altai Protocol Library New Reference: Perioperative Apalutamide in High-Risk Localized Prostate Cancer U. Darda Bayraktar, MD 2026-06-17
Altai Protocol Library New Protocol: Zanidatamab with Chemotherapy for Metastatic HER2-Positive Gastroesophageal Cancer U. Darda Bayraktar, MD 2026-06-15
Altai Protocol Library New Reference: Fixed-Duration Venetoclax- Obinutuzumab for Untreated CLL U. Darda Bayraktar, MD 2026-06-15
Altai Protocol Library New Reference: Tucatinib with Trastuzumab and Pertuzumab for HER2-Positive Metastatic Breast Cancer U. Darda Bayraktar, MD 2026-06-15
Altai Protocol Library New Protocol: Neoadjuvant Endocrine Therapy with Trastuzumab and Pertuzumab for Triple-Positive Breast Cancer U. Darda Bayraktar, MD 2026-06-15
Altai Protocol Library New Reference: Teclistamab for Relapsed / Refractory Multiple Myeloma U. Darda Bayraktar, MD 2026-06-15
Altai Protocol Library New Reference: Tebentafusp for Metastatic Uveal Melanoma U. Darda Bayraktar, MD 2026-06-15
